NEW ORLEANS — In this Healio Video Perspective from the ARVO meeting, Roger A. Goldberg, MD, MBA, discusses results from the YOSEMITE and RHINE studies.
The trials compared aflibercept to faricimab for the treatment of diabetic macular edema.
“Faricimab did a better job at reducing macular leakage vs. aflibercept after four loading doses of both drugs,” Goldberg said.
NEW ORLEANS — In this Healio Video Perspective from the ARVO meeting, Roger A. Goldberg, MD, MBA, discusses results from the YOSEMITE and RHINE studies.
The trials compared aflibercept to faricimab for the treatment of diabetic macular edema.
“Faricimab did a better job at reducing macular leakage vs. aflibercept after four loading doses of both drugs,” Goldberg said.
